Table 1.
Antibody | Epitopes | Type | Dilution | Resource | Reference |
---|---|---|---|---|---|
TTBK1 | TTBK1 kinase domain | M | 1:100 | Ikezu laboratory | This manuscript |
GFAP | Glial fibrillary acidic protein | P | 1:2000 | Dako | (Yamamoto et al., 2005, 2007) |
IBA1 | C-terminal protein | P | 1:1000 | Dr. S. Kohsaka | (Ito et al., 1998) |
Synaptophysin | Synaptosome preparation | M | 1:2000 | Sigma | (Murphy et al., 2000) |
Synaptotagmin | Brain synaptic junctional protein complexes | M | 1:2000 | Abcam | (Rastaldi et al., 2006) |
Phospho-NF | Phosphorylated neurofilament | M | 1:200 | Dako | (Gorantla et al., 2007) |
Phospho-APP | Thr668 | P | 1:250 | Cell Signaling Technology | (Kins et al., 2003) |
Phospho-GSK3α/β | Tyr279/216 | M | 1:200 | Upstate Biotechnology | (Allen et al., 2002) |
Phospho-GSK3α/β | Ser21/9 | P | 1:200 | Cell Signaling Technology | (Allen et al., 2002) |
GSK3β | C-terminal protein | P | 1:200 | Santa Cruz Biotechnology | (Allen et al., 2002) |
PHF-1 | P-tau Ser396 and Ser404 | M | 1:100 | Dr. P. Davies | (Greenberg et al., 1992) |
AT8 | P-tau Ser199, Ser202, and Thr205 | M | 1:200 | Innogenetics | (Biernat et al., 1992) |
12E8 | P-tau Ser262 and/or Ser356 | M | 1:2000 | Elan Pharmaceuticals | (Seubert et al., 1995) |
pS422 | P-tau Ser422 | P | 1:100 | Dr. A. Delacourte | (Bussière et al., 1999) |
AT100 | P-tau Ser212 and Thr214 | M | 1:100 | Pierce | (Zheng-Fischhöfer et al., 1998) |
M, Monoclonal; P, polyclonal.